I agree it's a long shot Orbey but the company was in an interesting geographical position towards the end of last week following the completion of the NGPT Summit in San Fransisco.
Not only where all current partners present Janssen, Genentech, Mediiumne & Pfizer but also a long line of others that may indeed be those in current negotiations GSK, Genzyme, Boehringer Ingelheim, Bristol Myers Squibb, Daiichisankyo, Eli Lilly, Abbott, Takeda, Novartis & Merck.
A good point to touch base on current collaborations especially considering Roches candidate is now with Genentech based in San Fransisco as is Pfizers now in their own R&D facilities also located in SF.
Both PW & NW in the US aligning with 6 month mark of J&J's deal being reached ?
Maybe wishful thinking maybe not but interesting regardless
PYC Price at posting:
4.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)